Covered recipient · General Payments record
DANA DENISE WICKER
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner
General Payments · PY2021–2024
$1,693.51
- Reported across 110 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $316.30 | 18 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $142.09 | 10 |
| Lilly USA, LLC | $46.05 | 2 |
| Acerta Pharma LLC | $36.17 | 2 |
| Bayer HealthCare Pharmaceuticals Inc. | $26.67 | 1 |
| ABBVIE INC. | $22.15 | 1 |
| GlaxoSmithKline, LLC. | $21.87 | 1 |
| DEXCOM, INC. | $21.30 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $22.15 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108408550 | CMS |
| AstraZeneca Pharmaceuticals LP | $19.31 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104481658 | CMS |
| AstraZeneca Pharmaceuticals LP | $16.86 | 11/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105868593 | CMS |
| Bayer Healthcare Pharmaceuticals Inc. | $26.67 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086344895 | CMS |
| Dexcom, Inc. | $21.30 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153356180 | CMS |
| GlaxoSmithKline, LLC. | $21.87 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115723460 | CMS |
| Lilly USA, LLC | $20.60 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135561918 | CMS |
| Lilly USA, LLC | $25.45 | 05/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135598561 | CMS |
| Novo Nordisk Inc | $3.11 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100497417 | CMS |
| Novo Nordisk Inc | $15.24 | 03/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100313593 | CMS |
| Novo Nordisk Inc | $7.18 | 05/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100510149 | CMS |
| Novo Nordisk Inc | $11.25 | 05/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100652609 | CMS |
| Novo Nordisk Inc | $11.16 | 05/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100382485 | CMS |
| Novo Nordisk Inc | $14.96 | 07/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100495137 | CMS |
| Novo Nordisk Inc | $10.90 | 07/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100540202 | CMS |
| Novo Nordisk Inc | $33.73 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100236864 | CMS |
| Novo Nordisk Inc | $26.32 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100532087 | CMS |
| Novo Nordisk Inc | $8.24 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100639996 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.